Jane M. Grant-Kels MD, FAAD
Professor of Dermatology, Pathology, and Pediatrics; Vice Chair, Department of Dermatology; Director, Cutaneous Oncology and Melanoma Program; University of Connecticut Health Center and School of Medicine, Farmington, Connecticut; Adjunct Professor of Dermatology, University of Florida, Gainesville, FloridaDr. Jane Grant-Kels is Professor and founding Chair of the Department of Dermatology at the University of Connecticut (UCONN) Health Center and Medical School. She remains the founding Director of the Cutaneous Oncology Center and the Melanoma Program. Additionally, she is an Adjunct Professor of Dermatology at the University of Florida in Gainesville.
Dr. Grant-Kels specializes in cutaneous oncology and pigmented lesions of the skin. She founded the dermatology department at UCONN. She was instrumental in the development of the Women’s Health Center at UCONN and, most recently, initiated a Cutaneous Oncology Center within the Neag Cancer Center and Department of Dermatology.
Dr. Grant-Kels received her medical degree from Cornell University Medical College in New York. She trained in pediatrics and dermatology at the New York Hospital of Cornell Medical Center. She then completed a dermatopathology fellowship at New York University Medical Center.
Disclosures
- Advisory board and Chief Medical Officer: Veradermics
- Medical advisor: DermaSensor
Recent Contributions to PracticeUpdate:
- Surgical Techniques and Presurgical Mapping of Lentigo Maligna and Lentigo Maligna Melanoma by Reflectance Confocal Microscopy
- Risk of Melanoma in Patients With Basal Cell Carcinoma
- 2022 Top Story in Dermatology: Is Melanoma Overdiagnosed?
- Effect of Reflectance Confocal Microscopy for Suspect Lesions on Diagnostic Accuracy in Melanoma
- 2021 Top Story in Dermatology: New Ways of Classifying and Treating Melanoma
- Planning Slow Mohs Excision Margins for Lentigo Maligna
- 2020 Top Stories in Dermatology: On the Right Path in Melanoma Treatment
- Lifetime History of Total Body Skin Examinations in Patients With Disabilities
- Recognition of Atopic Keratoconjunctivitis During Treatment With Dupilumab for Atopic Dermatitis
- Palliative Care in Dermatology